BioPortUSA a new partnership announced today with BEO Berlin, one of Germany’s leading regulatory consulting firms for the medical device industry. “Having access to BEO Berlin will allow us to better support our US clients in the med-tech field who are interested in expanding into the German market” stated Mark Lesselroth, CEO of Bioport. In addition to helping companies with their CE registration, BEO Berlin can also help them with the new MDR regulations which will go into effect in 2020. In addition, BEO Berlin is the founding member of a Pan-European Network of Regulatory Consultancies called EUMMAN (European Medical Market Access) which provides a platform for helping Med-tech companies beyond Germany gain regulatory approval.
“Having access to a partner in the USA who can help us better manage the needs of our German clients with FDA approval among other things, is something we are quite excited about” said MIchael Vent, President of BEO Berlin. Together, both companies can make a difference in helping international medical technology companies expand their business on a global level.